Medullary thyroid cancer (MTC) accounts for 3–10% of all thyroid malignancies and can be classed as “sporadic” (SMTC; 75%) or “hereditary” (HMTC; 25%) on the basis of germline RET gene mutation status and clinical phenotype 1. Here, RET is linked to medullary thyroid gland carcinoma.